Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 2
1999 2
2001 4
2003 1
2005 3
2006 1
2007 6
2008 4
2009 3
2010 3
2011 5
2012 3
2013 2
2014 2
2015 1
2016 2
2017 1
2018 3
2019 1
2020 1
2021 1
2022 3
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19.
Rümke LW, Smit WL, Bossink A, Limonard GJM, Muilwijk D, Haas LEM, Reusken C, van der Wal S, Thio BJ, van Os YMG, Gremmels H, Beekman JM, Nijhuis M, Wensing AMJ, Heron M, Thijsen SFT. Rümke LW, et al. Among authors: bossink a. Front Immunol. 2023 Apr 17;14:1046639. doi: 10.3389/fimmu.2023.1046639. eCollection 2023. Front Immunol. 2023. PMID: 37168853 Free PMC article.
QuantiFERON-plus does not discriminate between active and latent tuberculosis.
Hofland RW, Bossink AWJ, Nierkens S, Paardekooper SPA, van den Broek BTA, Lammers JJ, van Haeften I, Thijsen SFT. Hofland RW, et al. Among authors: bossink awj. Infect Dis (Lond). 2018 Jun;50(6):479-482. doi: 10.1080/23744235.2018.1425550. Epub 2018 Jan 15. Infect Dis (Lond). 2018. PMID: 29334817 No abstract available.
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.
Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Schölvinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C. Solovic I, et al. Among authors: bossink a. Eur Respir J. 2010 Nov;36(5):1185-206. doi: 10.1183/09031936.00028510. Epub 2010 Jun 7. Eur Respir J. 2010. PMID: 20530046 Free article.
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.
Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D. Sester M, et al. Among authors: bossink a. Eur Respir J. 2011 Jan;37(1):100-11. doi: 10.1183/09031936.00114810. Epub 2010 Sep 16. Eur Respir J. 2011. PMID: 20847080 Free article. Review.
Unilateral tongue atrophy and pulmonary malignancy.
Schulkes KJ, Bossink AW. Schulkes KJ, et al. Among authors: bossink aw. Neth J Med. 2013 Jan;71(1):32-5. Neth J Med. 2013. PMID: 23412822 Free article. No abstract available.
Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19.
Smit WL, van Tol S, van der Wal S, van Vulpen F, la Grouw S, van Lelyveld L, Limonard G, Bossink A, Godeke GJ, Shrestha S, Reimerink J, Eggink D, Reusken C, Heron M, Thijsen S. Smit WL, et al. Among authors: bossink a. Front Immunol. 2022 Mar 9;13:839367. doi: 10.3389/fimmu.2022.839367. eCollection 2022. Front Immunol. 2022. PMID: 35355988 Free PMC article.
51 results